I10 Q61.4 Q60
Conditions
Interventions
Group 1: Children and teenagers with renal dysplasia, renal hypoplasia or essential hypertension are evaluated regarding certain medication (NSAIDs, metamizole, RAAS-inhibitors) during pregnancy (case
Sponsors
Pharmakovigilanzzentrum Embryonaltoxikologie Charité-Universitätsmedizin
Eligibility
Sex/Gender
All
Age
No minimum to 16 Years
Inclusion criteria
Inclusion criteria: Patients who had an apointment in the pediatric clinic for nephrology in the years 2015 and 2016.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Are renal hypoplasia or renal dysplasia or hypertension in children and adolescents more frequent when the mother has taken an NSAID, metamizole or RAAS-inhibitor in the second half of pregnancy? For this purpose, all patients who were seen in the Charité clinic for pediatric nephrology in the past two years will be contacted by questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Are there any signs of a minimum exposure time and/or a minimum dose? For this purpose, all patients who were seen in the Charité clinic for pediatric nephrology in the past two years will be contacted by questionnaire. | — |
Countries
Germany
Contacts
Public ContactStephanie Padberg
Pharmakovigilanzzentrum Embryonaltoxikologie Charité-Universitätsmedizin
Outcome results
None listed